Impact of Flavonoids on Fatigue in Patients with RRMS

A recent study sought to determine the impact of flavonoids on fatigue in relapsing and remitting multiple sclerosis (RRMS).

Nine out of 10 people with multiple sclerosis experience fatigue, which can be extremely difficult to treat and have adverse effects on health and quality of life. Dark chocolate containing 70% to 85% cocoa solids is well known for its high antioxidant and flavonoid content and has been shown in a previous small randomized controlled pilot study to suggest an increase in quality of sleep and reduction in fatigue.

Researchers in this trial enrolled 40 patients recently diagnosed with RRMS in a parallel, randomized, double-blind, placebo-controlled trial in order to analyze the feasibility and efficacy of a flavonoid intervention. Patients were randomized to a high (n = 19) or low (n = 21) flavonoid groups.

Participants were provided a cocoa beverage mixed with heated rice milk by the lead researcher at baseline and at week 3, and they were asked to consume the drink in their homes daily. The beverage was consumed after an overnight fast at the same time each morning. After the beverage was consumed, participants were instructed to wait 30 minutes before eating any other food or beverage and/or take their medication.

Throughout the 6-week intervention participants were asked to rate their level of fatigue on a numerical scale from 1 to 10 (10 being the worst). Patients rated their level of fatigue 3 times per day for 6 weeks. Fatigability was measured at baseline and week 6 using a 6-minute walk test.

Continue reading on The American Journal of Managed Care. 


Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Related Articles

Top news of the day from across the health care landscape.
Investigators aim to develop cellular models to mimic the biological processes responsible for the onset of multiple sclerosis.
Obesity may increase severity of disability in patients with relapsing-remitting multiple sclerosis.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$